ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2022 and some content may be unavailable. To unlock all content for 2022, please visit the archives.

Abstract: TH-PO020

Assessing the Value of "A Family Journey" Community Program for Supporting Pursuit of Preemptive Living Kidney Transplantation

Session Information

  • Educational Research
    November 03, 2022 | Location: Exhibit Hall, Orange County Convention Center‚ West Building
    Abstract Time: 10:00 AM - 12:00 PM

Category: Educational Research

  • 900 Educational Research

Authors

  • Cruz, Bethany, Houston Methodist Hospital, Houston, Texas, United States
  • Gaber, Ahmed Osama, Houston Methodist Hospital, Houston, Texas, United States
  • Sharp, Joseph D., Houston Methodist Hospital, Houston, Texas, United States
  • Bosie, Vernell, Houston Methodist Hospital, Houston, Texas, United States
  • Corkrean, Julie, Houston Methodist Hospital, Houston, Texas, United States
  • Graviss, Edward A., Houston Methodist Hospital, Houston, Texas, United States
  • Nguyen, Duc T., Houston Methodist Hospital, Houston, Texas, United States
  • Bobu, Alexis, Houston Methodist Hospital, Houston, Texas, United States
  • Waterman, Amy D., Houston Methodist Hospital, Houston, Texas, United States
Background

Outreach to patients not yet in kidney failure and their support network may result in more preemptive living donor transplants (PLDT). We examined characteristics of kidney patients who participated in an education program, "A Family Journey," and its impact on PLDT.

Methods

Kidney patients not yet on dialysis were invited to attend "A Family Journey," a 1.5-hour education program at the onset of transplant evaluation. Educational topics discussed included the advantages of having a living donor kidney transplant and PLDT, training on how to seek donors, and available financial resources. Using EMR data and living donor pre-screening portals, we tracked demographic data, the number of living donor inquiries, and PLDT- actions taken by patients attending and not attending the class.

Results

Between 2019-2022, 11 in-person and 25 virtual sessions occurred. Of the 466 patients referred to "A Family Journey" class, 333 (71%) attended the class, with those attending being more likely to be White (39.6% vs. 36.8%, p=0.71), African American (26.4% vs. 22.5%, p=0.74), have commercial insurance (62.7% vs. 41.3%, p=0.003), and have incomes over $75,000 (24.9% vs. 18.0%, p=0.006) (Table). Compared to others, attendees were more likely to finish evaluation (81% vs. 65%, p<0.001), have a living donor inquiry (52% vs. 32%, p<0.001), and receive a PLDT (14% vs. 0.07%, p<0.001).

Conclusion

This PDKT-focused community education class was well attended with patients having more living donor inquiries and PLDTs compared to those who didn't attend. Further randomized controlled trials needed to determine how best to reach disparate communities with less access to PLDT.